IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q3 2024 Holdings

Filed 2024-11-08 | 3 holdings | $90.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$55.5M2,266,93461.5%
Lyell Immunopharma IncCOM55083R104$27.8M20,162,33230.8%
Prime Medicine Inc(PRME)COM74168J101$6.9M1,792,2107.7%